Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood.
Kobayashi
Y
Y
Uchida
H
H
Kawakami
Y
Y
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D001398:Aztreonam / Q000494:pharmacology; D003982:Dibekacin / Q000031:analogs & derivatives / Q000494:pharmacology; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D014031:Tobramycin / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; D001398:Aztreonam; C031986:arbekacin; D014031:Tobramycin